Drug Development for Noncastrate Prostate Cancer in a Changed Therapeutic Landscape

Nature Reviews Clinical Oncology - United Kingdom
doi 10.1038/nrclinonc.2017.177
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

HMGB1: A Promising Therapeutic Target for Prostate Cancer

Prostate Cancer
Cancer ResearchOncologyUrology
2013English

Functional Imaging for Prostate Cancer: Therapeutic Implications

Seminars in Nuclear Medicine
Nuclear MedicineRadiologyImaging
2012English

The Genomic Landscape of Prostate Cancer

Frontiers in Endocrinology
EndocrinologyMetabolismDiabetes
2012English

Targeting CDK9: A Promising Therapeutic Opportunity in Prostate Cancer

Endocrine-Related Cancer
Cancer ResearchEndocrinologyOncologyMetabolismDiabetes
2016English

Educational Standards and Australia: A Changed Landscape

Revista Brasileira de Estudos Pedagógicos
2016English

Therapeutic Landscape in Mutational Triple Negative Breast Cancer

Molecular Cancer
Cancer ResearchOncologyMolecular Medicine
2018English

LINE-1 as a Therapeutic Target for Castration-Resistant Prostate Cancer

Frontiers in Bioscience - Landmark
ImmunologyMolecular BiologyBiochemistryMicrobiology MedicineGenetics
2018English

Ailanthone: A New Potential Drug for Castration-Resistant Prostate Cancer

Chinese Journal of Cancer
2017English

APC8015, a Therapeutic Vaccine for Prostate Cancer, Targets Prostatic Acid Phosphatase

Cancer Biology and Therapy
Cancer ResearchOncologyMolecular MedicinePharmacology
2005English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy